Huapont Life Sciences controller unpledges significant shareholding

Huapont Life Sciences Co., Ltd. announced that its de facto controller, Mr. Zhang Songshan, has unpledged 29.91 million shares, representing 25.54% of his total holdings and 1.51% of the company's total share capital. The unpledging, which took place on September 1, 2025, from a pledge initiated on October 24, 2024, involved shares held with Bohai International Trust Co., Ltd.

Following this transaction, Mr. Zhang Songshan's pledged shares now stand at 61.91 million, accounting for 52.87% of his personal holdings and 3.13% of the company's total shares. A significant portion of these, 50.82 million shares, are classified as restricted and frozen, representing 82.09% of his pledged shares. His unpledged holdings include 37 million restricted and frozen shares, making up 67.05% of his total unpledged shares.

Collectively, the de facto controller and his concerted parties—including Chongqing Huabang Zhuoyuan Technology Co., Ltd., Mr. Zhang Yizhuo, and Ms. Zhao Danlin—have 268.99 million shares pledged, representing 49.54% of their combined holdings and 13.59% of the company's total share capital. Of these, 50.82 million pledged shares are restricted or frozen.